HUMABODY

Live / Registered — Registered — partial invalidation of extension of protection (as of 27 Jun 2024)

What this means for you

Registered since 14 Mar 2017. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79179556
Registration number
5158366
Mark type
Stylized text
Filed
17 Dec 2014
Published for opposition
20 Sept 2016
Registered
14 Mar 2017
Attorney of record
Rebecca Liebowitz

Goods and services

  • Class 001 — Chemicals: chemicals used in industry and science; [ chemical test kits for in vitro testing for laboratory research purposes; ] biochemicals, namely, monoclonal antibodies and antibody fragments all being proteins for in vitro scientific and laboratory research use; biochemicals, namely, monoclonal antibodies and antibody fragments for in vitro scientific and laboratory research use; antibodies and antibody fragments all being protein in raw material form for scientific research purposes; antibody reagents used for the detection of antigens in cell and tissue analysis for scientific and laboratory in vitro diagnostic use; antibodies and antibody fragments all being proteins for industrial use in the discovery, preclinical and clinical development of therapeutic products
  • Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of cancer [ , autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases ] ; veterinary preparations for the treatment of cancer [ , autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases ] ; therapeutic pharmaceutical preparations in the nature of antibodies and antibody fragments for medical and veterinary purposes; antibodies being pharmaceutical preparations for the treatment of cancer [ , autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases ] ; antibody fragments being pharmaceutical preparations for the treatment of cancer [ , autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases] ; antibody therapeutics in the nature of therapeutic agents for the treatment of cancer [ , autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases ] ; medical diagnostic reagents and veterinary diagnostic reagents in the nature of antibodies and antibody fragments; antibodies and antibody fragments being therapeutic pharmaceuticals for the treatment of cancer [ , autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases ] and or use in the manufacture of therapeutic products
  • Class 040 — Treatment of materials: [ Treatment and transformation of materials for others, namely, the manufacture of chemicals, biologicals, antibodies and antibody fragments; contract manufacturing services in the field of chemicals, biologicals, antibodies and antibody fragments; custom manufacture of therapies using antibodies and antibody fragments ]
  • Class 042 — Scientific and technological services: [ Scientific and technological services, namely, scientific research, analysis and testing and research and design in the field of chemicals, biologicals, antibodies and antibody fragments; Scientific laboratory services in the field of antibodies and antibody fragments; research in the field of the development of antibodies and antibody fragments; provision of scientific information in the field of antibodies and antibody fragments for medical and veterinary purposes; engineering of antibodies and antibody fragments; scientific services, namely, drug discovery, preclinical and clinical development of therapeutic products; consultancy services relating thereto, namely, consulting in the field of antibody and antibody fragment design ]

Owner

Prosecution history

  • 14 Mar 2026 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
  • 20 Jun 2025 — PARTIAL INVALIDATION PROCESSED BY THE IB
  • 12 May 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
  • 12 May 2025 — INVALIDATION PROCESSED
  • 12 May 2025 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
  • 27 Feb 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
  • 12 Dec 2024 — INTERNATIONAL REGISTRATION RENEWED
  • 08 Nov 2024 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
  • 27 Jun 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
  • 27 Jun 2024 — REGISTERED - PARTIAL SEC 71 ACCEPTED
  • 07 May 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 27 Oct 2023 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
  • 13 Sept 2023 — TEAS SECTION 71 RECEIVED
  • 19 Aug 2023 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
  • 14 Mar 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

View this trademark record on Marksy